Research advances in early screening and diagnosis of hepatocellular carcinoma
10.3969/j.issn.1001-5256.2023.06.033
- VernacularTitle:肝细胞癌早期筛查和诊断的研究进展
- Author:
Jiaxin HAN
1
;
Yuqiang MI
2
;
Liang XU
2
Author Information
1. Clinical School of The Second People's Hospital of Tianjin Medical University, Tianjin 300192, China
2. Tianjin Hepatopathy Research Institute, Tianjin Second People's Hospital, Tianjin 300192, China
- Publication Type:Review
- Keywords:
Carcinoma;
Hepatocellular;
Early Detection of Cancer;
Early Diagnosis
- From:
Journal of Clinical Hepatology
2023;39(6):1468-1475
- CountryChina
- Language:Chinese
-
Abstract:
For the high-risk population, early screening and diagnosis are important measures to achieve good control of liver cancer and reduce the burden of liver cancer, and determining the high-risk population of liver cancer and formulating appropriate liver cancer screening strategies are the key to realizing the early screening and diagnosis of liver cancer. The risk assessment model for liver cancer is an important method for rapid and convenient identification of the high-risk population of liver cancer. Based on the risk stratification of liver cancer, the methods such as imaging technology, serological markers, liquid biopsy, metabolomics, and glycomics can be used for accurate early screening and diagnosis of liver cancer, so as to achieve the goal of early treatment.
